Arima Genomics
Arima Genomics is revolutionizing cancer diagnostics by leveraging whole-genome sequence and structure information. Their proprietary platform analyzes DNA organization to provide comprehensive insights for cancer therapy selection. The company operates a CLIA-certified clinical testing laboratory, Aventa, and offers advanced kits and informatics for researchers.
Funding Round: Series C
Funding Amount: $22M
Date: 17-Jun-2025
Investors: Illumina Ventures, John Stuelpnagel, Mostafa Ronaghi, Co-Win Ventures, Berkeley Catalyst Fund
Markets: Biotech, Oncology, Diagnostics
HQ: Carlsbad, California, United States
Founded: 2015
Website: https://www.arimagenomics.com
LinkedIn: https://www.linkedin.com/company/arima-genomics-inc-/
Twitter: https://x.com/ArimaGenomics
Crunchbase: https://www.crunchbase.com/organization/arima-genomics
Leave a Comment
Comments
No comments yet.